24.01.2013 Views

Sirtex Cover.proof 11 - School of Educators

Sirtex Cover.proof 11 - School of Educators

Sirtex Cover.proof 11 - School of Educators

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Independent Accountants Report<br />

(e) Receivables<br />

Trade receivables and other receivables are recorded at amounts due less any provision for doubtful<br />

debts.<br />

(f) Plant and Equipment<br />

Plant and equipment are brought to account at cost or at independent or directors’ valuation, less,<br />

where applicable, any accumulated depreciation or amortisation. The carrying amount <strong>of</strong> plant and<br />

equipment is reviewed annually by directors to ensure it is not in excess <strong>of</strong> the recoverable amount<br />

from those assets. The recoverable amount is assessed on the basis <strong>of</strong> the expected net cash flows<br />

which will be received from the assets employment and subsequent disposal. The expected net cash<br />

flows have not been discounted to their present values in determining recoverable amount.<br />

Depreciation is provided on plant and equipment. Depreciation is calculated on a diminishing value<br />

basis so as to write <strong>of</strong>f the net cost <strong>of</strong> each asset over its useful life. The following estimated useful lives<br />

are used in the calculation <strong>of</strong> depreciation:<br />

– Plant and Equipment 2 – 5 years<br />

(g) Leases<br />

Leases <strong>of</strong> fixed assets, where substantially all the risks and benefits incidental to the ownership <strong>of</strong> the<br />

asset, but not legal ownership, are transferred to the company are classified as finance leases. Finance<br />

leases are capitalised recording an asset and a liability equal to the present value <strong>of</strong> the minimum lease<br />

payments, including any guaranteed residual value. Leased assets are amortised over their estimated<br />

useful lives. Lease payments are allocated between the reduction <strong>of</strong> the lease liability and the lease<br />

interest expense for the period.<br />

Lease payments under operating leases, where substantially all the risks and benefits remain with the<br />

lessor, are charged as expenses in the years in which they are incurred.<br />

(h) Investments<br />

Investments brought to account are at cost or at directors’ valuation. The carrying amount <strong>of</strong><br />

investments is reviewed annually by directors to ensure it is not in excess <strong>of</strong> the recoverable amount <strong>of</strong><br />

these investments. The recoverable amount is assessed from the shares’ current market value or the<br />

underlying net assets in the particular entities. The expected net cash flows from investments have not<br />

been discounted to their present value in determining the recoverable amounts, except where stated.<br />

Dividends are brought to account in the pr<strong>of</strong>it and loss account when received.<br />

(i) Employee Entitlements<br />

Provision is made for the liability for employee entitlements arising from services rendered by<br />

employees to balance date. Employee entitlements expected to be settled within one year together with<br />

entitlements arising from wages and salaries, annual leave and sick leave which will be settled after one<br />

year, have been measured at their nominal amount. Other employee entitlements payable later than<br />

one year have been measured at the present value <strong>of</strong> the estimated future cash out flows to be made<br />

for those entitlements.<br />

Contributions are made by the company to employee superannuation funds and are charged as<br />

expenses when incurred.<br />

(j) Intellectual Property<br />

The acquisition cost <strong>of</strong> intellectual property is recorded at cost and amortised on a straight-line basis<br />

over the period <strong>of</strong> the patents.<br />

(k) Research and Development Costs<br />

Research and development costs are written <strong>of</strong>f as and when they are incurred.<br />

<strong>Sirtex</strong> Medical Prospectus 2000<br />

39

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!